Melanoma is a type of skin cancer that starts in pigment‑making cells and can spread if not treated. People with melanoma may notice a new spot or a changing mole that is asymmetrical, has uneven edges, or itches or bleeds. It can affect adults of any age and occasionally teens, and risk rises with fair skin, heavy sun or UV exposure, many moles, or a family history. Treatment often includes surgical removal, and some need immunotherapy, targeted drugs, or radiation, and many do well when melanoma is found early. The outlook varies by stage, so early symptoms of melanoma should prompt a quick check by a clinician.
Overview
MelanomaSymptoms
Melanoma often shows up as a new spot or a mole that changes—getting darker, uneven, larger, itchy, or bleeding. Early symptoms of melanoma include a sore that won’t heal or a dark streak under a nail. See a clinician promptly.
Outlook and prognosis
Many people with melanoma do well when it’s found early, often needing only minor surgery and regular skin checks. Deeper or spread melanoma needs more treatment, but modern immunotherapy and targeted drugs have improved survival. Ongoing follow-up is important.
Causes and risk factors
Melanoma often stems from DNA damage from ultraviolet (UV) light, especially intense, blistering sunburns or tanning beds. Risk rises with fair skin, many or atypical moles, family or personal history, immunosuppression, certain inherited variants, and high UV exposure.
Genetic influences
Genetics plays a meaningful role in melanoma. Inherited variants in genes like CDKN2A raise lifetime risk, especially with multiple close relatives affected or many atypical moles. Most melanomas, though, arise from acquired DNA changes driven by UV exposure over time.
Diagnosis
Melanoma is diagnosed after a focused skin exam, often with a dermatoscope, followed by a biopsy of the spot. A pathologist confirms the diagnosis of melanoma. If cancer is found, staging may include sentinel lymph node biopsy and imaging.
Treatment and drugs
Melanoma care often combines surgery to remove the spot with medicines that help the immune system or target tumor changes. Depending on stage, doctors may add radiation or preventive drug therapy after surgery. Regular skin checks and imaging guide each step.
Symptoms
Melanoma symptoms often show up as changes on the skin—especially a new spot or a mole that looks different from others. You might notice small changes at first. The early symptoms of melanoma can include a spot that grows, changes color, or starts to itch, bleed, or feel sore. Less commonly, melanoma can start under a nail, on the palm or sole, in the mouth or genitals, or in an eye, leading to location-specific symptoms.
Early on, this might look like a mole that wasn’t there before or one that starts to stand out from the rest. A spot that looks different from your other moles can be an early sign of melanoma. Pay attention if it keeps changing over weeks.
One half of the spot doesn’t match the other half. This uneven outline is a common warning sign. Compare both sides as if folding it in half.
The borders look irregular, not smooth or round. Edges may appear scalloped, notched, or fade into nearby skin. Clear, even borders are less concerning.
Shades of brown, black, or tan show up in the same spot, or new colors like red, blue, or white appear. Uneven color can point toward melanoma. Very dark and very light areas mixed together are another clue.
How people usually first notice Melanoma?
Many people first notice melanoma as a new spot on the skin or a changing mole that looks different from the others. Warning signs often follow the ABCDEs: Asymmetry, uneven Borders, mixed or very dark Color, Diameter larger than about 6 mm (¼ inch) or any growth, and Evolution—any change in size, shape, color, texture, or symptoms like itching or bleeding. Another red flag is the “ugly duckling” sign, a mole that doesn’t match your usual pattern; if you see any of these first signs of melanoma, it’s worth getting a prompt skin check.
Types of Melanoma
Melanoma has several well-recognized clinical types that behave a bit differently on the skin and under the microscope. Knowing the types of melanoma helps explain why early symptoms of melanoma can look so varied—from a flat, slowly changing patch to a rapidly growing, raised spot. Symptoms don’t always look the same for everyone.
Superficial spreading
This is the most common type and often starts as a flat or slightly raised spot that slowly spreads outward. Color can be uneven with shades of brown, black, or sometimes pink. It tends to grow across the skin before going deeper.
Nodular melanoma
This type grows more quickly and tends to be dome-shaped or raised from early on. It may look uniform in color—often black, blue-black, or even skin-colored or red. Because it grows downward sooner, it’s more likely to bleed or feel tender.
Lentigo maligna
Usually appears on sun-exposed areas like the face in older adults. It often starts as a large, flat, tan-to-brown patch with uneven edges that changes slowly over years. When it starts to invade deeper layers, it’s called lentigo maligna melanoma.
Acral lentiginous
Found on palms, soles, or under nails, and can affect people of any skin tone. It may show as a dark streak under a nail or a flat, unevenly colored patch on the sole or palm. Because it’s in less obvious places, diagnosis is sometimes delayed.
Amelanotic melanoma
Lacks the usual dark pigment, so it can look pink, red, or skin-colored. It may be mistaken for a pimple, rash, or bug bite at first. Paying attention to changes in size, shape, or bleeding can help catch it sooner.
Desmoplastic melanoma
Often appears as a firm, scar-like or skin-colored area, especially on sun-damaged skin. It may be less pigmented and can feel thicker or harder than the surrounding skin. Nerve involvement can cause tingling or discomfort in some cases.
Mucosal melanoma
Arises on moist internal surfaces like the mouth, nasal passages, or genital/anal areas. It may cause bleeding, a lump, or persistent soreness in those regions. Because it’s hidden, it’s often found later and needs prompt specialist care.
Uveal/ocular melanoma
Develops inside the eye, most commonly in the uvea. Symptoms may include blurred vision, floaters, or a dark spot on the iris, but many are found during routine eye exams. Treatment and follow-up are coordinated with an eye cancer specialist.
What genetics can tell you about symptoms
Certain inherited changes in CDKN2A can lead to many large, irregular moles and earlier, multiple melanomas in a family. Variants in MC1R, common in people with red hair and very fair skin, raise sun sensitivity and the risk of freckling and melanoma.
Causes and risk factors
Most melanoma starts when ultraviolet light damages skin cells and causes harmful gene changes.
Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Risk factors for melanoma include frequent sunburns, indoor tanning, and older age.
Biological risks include fair or freckled skin, many or unusual moles, and a weak immune system.
Genetics also play a role, since melanoma can run in families and gene changes can build up in skin over time.
Environmental and biological risk factors
Several environmental and body-based factors can raise the chance of melanoma. Doctors often group risks into internal (biological) and external (environmental). Knowing these can help you focus on what to monitor with your care team, including early symptoms of melanoma.
UV rays from strong sunlight can damage pigment-producing skin cells. Repeated or intense exposure raises the chance that melanoma will develop. UV levels are often highest around midday and during summer months.
Exposure to artificial UV from tanning lamps or beds can injure skin cells in the same way as the sun. This added UV dose increases melanoma risk, especially with higher total exposure over time.
Living closer to the equator or at high altitude brings stronger UV intensity. More direct sun and thinner atmosphere mean more skin cell damage that can lead to melanoma. Areas with a high UV index add to lifetime exposure.
A history of blistering sunburns signals heavy UV injury to the skin. That damage raises melanoma risk years later, even if burns were infrequent. Childhood or teen sunburns may be particularly impactful.
Genetic risk factors
For some people, melanoma risk runs in the family due to inherited changes in certain genes. Carrying a genetic change doesn’t guarantee the condition will appear. These genetic risk factors for melanoma can raise lifetime risk, lead to earlier diagnoses, or increase the chance of more than one melanoma. Doctors may suggest genetic testing when several relatives are affected or when melanoma occurs at a young age.
Family history: When two or more close relatives have melanoma, inherited risk is more likely. Patterns such as early diagnosis or multiple separate melanomas in one person are important clues.
CDKN2A variants: Changes in the CDKN2A gene can greatly raise melanoma risk. Families may see diagnoses at younger ages and sometimes more than one separate melanoma.
CDK4 variants: Rare alterations in CDK4 disrupt normal cell‑growth checks and raise risk for this cancer. Family patterns often resemble those seen with CDKN2A changes.
BAP1 syndrome: Inherited BAP1 changes increase risk for melanoma, especially of the eye, and for certain other tumors. Some people develop small, dome‑shaped moles that doctors can recognize.
POT1 and shelterin: Variants in POT1, ACD, or TERF2IP affect telomere protection and can raise melanoma risk. Families may include several relatives with related cancers.
MITF E318K: This specific MITF change increases the chance of this cancer. It may also be linked with having more moles than average.
MC1R variants: Changes tied to red hair and freckling can increase risk for this cancer. Risk level varies with the number and type of MC1R changes.
Xeroderma pigmentosum: Inherited defects in DNA repair genes such as XPA or XPC cause very high melanoma risk. Cancers often appear in childhood or the teenage years.
Albinism (OCA): Gene changes that reduce melanin can increase skin cancer risk. People are born with much lighter skin and hair, and may have vision differences.
PTEN syndrome: Inherited PTEN changes may modestly raise skin cancer risk, sometimes including melanoma. Other features can include benign growths and a larger head size that doctors may note.
Li-Fraumeni syndrome: TP53 variants strongly increase many cancer risks and can include this skin cancer. People may be diagnosed much earlier than average.
BRCA2 variants: Some families with BRCA2 changes show a small but real increase in melanoma risk. The effect is milder than in genes that primarily drive melanoma.
High mole count: An inherited tendency to many or atypical moles increases risk for this cancer. Families may share this pattern along with earlier or multiple diagnoses.
Lifestyle risk factors
Several lifestyle behaviors can shift your risk of melanoma and influence outcomes. The most important lifestyle risk factors for melanoma relate to how and when you get UV exposure and how well you protect your skin. Other habits like alcohol use, body weight, and activity level may also play roles in risk or prognosis.
Using tanning beds delivers concentrated UV to the skin. Even occasional sessions raise melanoma risk; avoiding them lowers risk.
Repeated or blistering sunburns signal intense, damaging UV bursts. Preventing sunburns throughout life reduces melanoma risk.
Spending long periods outdoors between 10 a.m. and 4 p.m. increases UV intensity to the skin. Planning activities for early morning or evening and seeking shade decreases risk.
Skipping sunscreen or applying too little leaves skin under-protected. Using broad-spectrum SPF 30+ and reapplying every two hours improves protection and may reduce melanoma incidence.
Risk prevention
Spending time outdoors is part of daily life, but strong ultraviolet (UV) light can raise the chance of melanoma. Small, steady habits make a real difference over time. Prevention is about lowering risk, not eliminating it completely. Regular skin checks also help spot early symptoms of melanoma, when treatment is most effective.
Build UV protection into routines like commuting, dog walks, and sports. These small steps reduce day-to-day melanoma risk.
Seek shade when the sun is strongest, usually 10 a.m.–4 p.m. (roughly 10:00–16:00). Planning outdoor time earlier or later lowers UV exposure.
Use SPF 30+ broad-spectrum sunscreen on exposed skin. Apply about 1 ounce (30 mL) for full body and reapply every 2 hours, or after swimming or sweating.
Wear long sleeves, long trousers, and a wide-brim hat; UV-blocking sunglasses protect eyes and eyelids. UPF-rated clothing adds extra melanoma protection for frequent sun exposure.
Transmission
Melanoma isn’t contagious. You can’t catch it or pass it on through touch, kissing, sex, coughing, or sharing towels and pools. Melanoma develops when skin cells become damaged—most often by ultraviolet (UV) light from the sun or tanning beds—not from an infection. In some families, the risk of melanoma can be inherited; about 1 in 10 cases occurs in people with a strong family history due to gene changes passed down from a parent. This isn’t genetic transmission of melanoma itself, but a higher chance of developing it; if you’re worried about how melanoma is inherited, a genetics professional can help you understand your personal risk.
When to test your genes
Consider genetic testing if melanoma runs strong in your family, you had melanoma at a young age, or multiple close relatives had melanoma or pancreatic cancer. Testing can guide earlier skin checks, mole mapping, and sun-protection plans, and sometimes tailored surveillance for other cancers. Ask a genetics professional to review your family history and choose the right test.
Diagnosis
You might notice a new spot or a mole that’s changing in size, shape, or color, especially one that looks different from the rest. Doctors usually begin with a careful skin exam and then confirm findings with a small tissue sample. Getting a diagnosis is often a turning point toward answers and support. The diagnosis of melanoma is confirmed under the microscope, and additional tests help determine how advanced it is and what treatments make sense.
A clinician looks closely at the entire skin surface for spots that stand out or show ABCDE warning signs. They also check lymph nodes and ask about changes you’ve noticed over time.
A handheld lighted scope helps reveal patterns and colors not seen with the naked eye. This improves accuracy when deciding which spots may need a biopsy for melanoma.
Standard photos or total‑body images can document baseline skin and track changes over months or years. This is especially helpful for people with many moles or hard‑to‑see areas.
The preferred method removes the whole suspicious spot with a narrow rim of normal skin. This gives the pathologist the best sample to confirm or rule out melanoma.
Stages of Melanoma
Staging describes how far melanoma has grown or spread and helps tailor care. Different tests may be suggested to help show the size of the melanoma, whether nearby lymph nodes are involved, and if there’s spread elsewhere. This can include a skin exam and biopsy, a sentinel lymph node biopsy, and scans such as ultrasound, CT, or PET-CT.
Stage 0
The melanoma cells are only in the top layer of skin (in situ) and have not invaded deeper. Surgery usually removes it completely with very high cure rates. Early symptoms of melanoma at this stage are often just changes in how a mole looks, not pain.
Stage I
The melanoma is thin (up to about 1–2 mm, roughly 0.04–0.08 in) and has not spread to lymph nodes. Removal with a margin of normal skin is standard, and the risk of spread is generally low. A sentinel lymph node biopsy may be considered in select cases to check for microscopic spread.
Stage II
The melanoma is thicker (often more than 2 mm, about 0.08 in) or shows surface breakdown (ulceration), but no spread to lymph nodes is found on exam. The risk of future spread is higher than in Stage I. Doctors may recommend a sentinel lymph node biopsy and, in some cases, baseline imaging.
Stage III
Melanoma has reached nearby lymph nodes or small melanoma deposits just under the skin near the original spot. You may notice a firm lump in the armpit, neck, or groin on the side of the melanoma. Treatment plans often include lymph node surgery and medicines that target melanoma cells throughout the body.
Stage IV
Melanoma has spread to distant organs such as the lungs, liver, brain, bones, or skin far from the original site. Symptoms vary by where it has spread—for example cough or shortness of breath with lung involvement, or headaches with brain involvement. Care focuses on whole-body treatments and managing symptoms to maintain quality of life.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with melanoma, outlook depends most on how early it’s found and removed. When melanoma is caught at an early stage, surgery often cures it and long-term survival is high. If it has spread to nearby lymph nodes or other organs, treatment is more complex and the chance of remission and long-term control is lower, but newer therapies have improved outcomes compared with a decade ago.
Prognosis refers to how a condition tends to change or stabilize over time. Early symptoms of melanoma, like a changing mole or a new spot that looks different from others, matter because catching changes early gives the best odds. Targeted drugs and immunotherapy have extended survival for many with advanced melanoma, though responses vary and some people have long remissions while others need ongoing treatment. Mortality is lowest for thin, localized tumors and higher when the cancer has spread; factors such as tumor thickness, ulceration, lymph node involvement, age, and overall health all play a role.
With ongoing care, many people maintain good quality of life after melanoma treatment. Regular skin checks, sun protection, and quick follow-up for new or changing spots help reduce risk of recurrence and support early detection of new melanomas. Talk with your doctor about what your personal outlook might look like, including stage-specific survival rates and how your treatment plan may influence them. Genetic testing can sometimes provide more insight into prognosis, especially when considering targeted therapies for advanced disease.
Long-term effects
Many living with melanoma think about what life looks like months and years after treatment, including energy, mood, and how the skin heals. Long-term effects vary widely, and not everyone has the same experience. What happens over time often depends on the melanoma stage at diagnosis, where it was located, and the treatments used. Some people also reflect on early symptoms of melanoma that were easy to miss, which can bring up mixed emotions about the past and future.
Melanoma can return in the skin near the original spot, in nearby lymph nodes, or in distant organs. The risk is usually highest in the first few years but late recurrences can happen.
If melanoma spreads, symptoms depend on where it goes, such as headaches or weakness if the brain is involved, or cough and shortness of breath if the lungs are affected. These changes tend to evolve over time.
People who have had melanoma are at higher risk of a new, separate melanoma later on. Doctors often monitor the whole skin surface and any changing moles.
Swelling of an arm, leg, or the trunk can occur after lymph node surgery or radiation. It may cause heaviness, reduced range of motion, and skin tightness.
How is it to live with Melanoma?
Living with melanoma often means living with uncertainty, frequent skin checks, and a calendar dotted with follow-up visits and imaging. Day to day, many people become more vigilant about sun protection, scars or changes on their skin, and the emotional whiplash of waiting for results; fatigue and treatment side effects can ebb and flow. Partners, family, and friends may share the worry and adjust routines for appointments and recovery, but they also become a crucial support team for reminders, rides, and encouragement. Over time, many find a new rhythm—protecting their skin, staying active when possible, and focusing on what they can control while leaning on their care team for clear plans and reassurance.
Treatment and drugs
Melanoma treatment focuses on removing the cancer, lowering the chance it comes back, and treating any spread. For early-stage melanoma, surgery to remove the spot and a small margin of normal skin is usually the main treatment, and some people also have a nearby lymph node checked or removed to see if cells have traveled. For more advanced melanoma, treatments can include immunotherapy (drugs that help your immune system find and attack cancer), targeted therapy for tumors with certain gene changes like BRAF, and, in select cases, radiation or chemotherapy. Treatment plans often combine several approaches, and may shift over time based on how the melanoma responds and how you feel. Ask your doctor about the best starting point for you, including clinical trials that may offer access to newer therapies.
Non-drug treatment
Non-drug care for melanoma centers on removing the tumor, checking nearby lymph nodes when needed, and building routines that protect your skin and well‑being long term. Non-drug treatments often lay the foundation for recovery, symptom control, and prevention of future skin damage. These approaches can be used alone for early disease or combined with medical treatments for more advanced melanoma. Your team will tailor options based on the tumor’s size, depth, location, and your overall health.
A surgeon removes the melanoma with a rim of healthy skin to lower the chance it returns. This is usually an outpatient procedure and cures many early melanomas.
A targeted check of the first lymph node that drains the melanoma helps show whether cancer has spread microscopically. Results guide follow-up and the need for additional treatment.
For some melanoma in situ on the face, tissue-sparing Mohs can remove cancer while preserving healthy skin. The surgeon examines margins during the visit to confirm clear removal.
Carefully aimed radiation can control melanoma in areas that are hard to operate on or ease pain from spread to bone or skin. It may also be used after surgery to lower the risk of local return in select cases.
Your genes may have an impact on how drugs work for you
Genes can affect how your body processes melanoma treatments, changing how well drugs work and what side effects you might feel. Variants in pathways that handle immune checkpoints or drug metabolism can guide dose choices and help personalize your treatment plan.
Pharmacological treatments
Medicines for melanoma aim to shrink tumors, help the immune system attack cancer cells, and lower the chance the cancer returns after surgery. Even if your melanoma was found through early symptoms of melanoma and removed, drug therapy may still be used to protect against relapse or to treat spread to lymph nodes or other organs. Options depend on tumor stage and gene changes, especially whether a BRAF mutation is present. Not everyone responds to the same medication in the same way.
Pembrolizumab or nivolumab help your immune system find and attack melanoma cells. They are used for advanced disease and as after-surgery (adjuvant) treatment in higher-risk stages. Side effects can include inflammation of organs, which doctors monitor and treat early.
Nivolumab with relatlimab (a LAG‑3 blocker) can boost immune attack when a single drug isn’t enough. It’s an option for untreated advanced melanoma. Side effects are generally manageable but can still be immune‑related.
Nivolumab plus ipilimumab is a stronger combination for advanced melanoma. It can lead to deeper responses but carries a higher risk of immune side effects. Doctors adjust treatment plans regularly to balance benefits and risks.
Ipilimumab can be used if PD‑1–based approaches aren’t suitable or have stopped working. It activates T‑cells but has a higher chance of immune side effects than PD‑1–only therapy. Close follow‑up helps manage problems early.
Genetic influences
Genetics play a role in melanoma for a minority of people, with inherited gene changes accounting for roughly 5–10% of cases. Family history is one of the strongest clues to a genetic influence. In some families, a single high-impact gene change—often in a gene that controls cell growth, such as CDKN2A—can raise lifetime risk and lead to multiple melanomas or earlier onset. More common, smaller-effect gene differences, including those tied to fair skin, red or blond hair, freckling, or having many moles, can also raise melanoma risk, especially alongside intense sun exposure or tanning beds. Not everyone who inherits a risk gene will develop melanoma, and many people with melanoma have no inherited risk; environment and chance still matter. If several relatives have melanoma, or you were diagnosed young or have multiple primary melanomas, asking about genetic counseling or exploring genetic testing for melanoma risk can help guide screening and prevention.
Is Melanoma genetic?
Genetics plays a meaningful role in melanoma. Inherited variants in genes like CDKN2A raise lifetime risk, especially with multiple close relatives affected or many atypical moles. Most melanomas, though, arise from acquired DNA changes driven by UV exposure over time.
Pharmacogenetics—how genetics influence drug effects
Treatment choices in melanoma often depend on the genes in the tumor and, in a few cases, on your own genetic makeup. If testing finds a BRAF V600 change, doctors may use paired targeted medicines (a BRAF inhibitor with a MEK inhibitor), while melanomas without this change typically don’t benefit from those drugs. Certain subtypes, such as acral or mucosal melanoma, can carry KIT changes that sometimes open the door to targeted options, and tumor profiling can also reveal NRAS or other alterations that may inform clinical trial choices. In uveal melanoma, a therapy called tebentafusp is available only for people who carry the HLA‑A*02:01 tissue type, showing how a person’s own HLA genes can determine access to a specific drug. For immunotherapy drugs such as PD‑1 or CTLA‑4 inhibitors, routine pharmacogenetic tests to predict who will respond or who will have side effects aren’t yet part of standard care, and decisions still rely on the overall clinical picture. Ask your doctor if pharmacogenetic testing for melanoma treatment could help tailor your plan, since the specific tests that matter depend on your melanoma type and stage.
Interactions with other conditions
People living with other health conditions may notice that melanoma behaves differently for them. Doctors call it a “comorbidity” when two conditions occur together. A weakened immune system—such as after an organ transplant or with untreated HIV—can raise the chance of melanoma and sometimes make it grow or return more quickly. Some autoimmune diseases and their treatments lower immune defenses; later, if melanoma is treated with immunotherapy, those autoimmune symptoms can flare, so care teams balance risks on both sides. Melanoma also clusters with a few other diseases: people with Parkinson’s disease have a higher-than-average chance of melanoma (and vice versa), and certain inherited changes can increase the risk of both melanoma and pancreatic cancer in some families. Having had other skin cancers can signal more sun damage overall, which means a higher risk of melanoma down the line. If you take long-term immune-suppressing medicines, tell your clinician about any new or changing moles or other early symptoms of melanoma so they can adjust screening and treatments with your full health picture in mind.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described unusual, dark skin growths that behaved more aggressively than typical moles. Family letters mentioned a “bad spot” that bled or spread; surgeons in the 18th and 19th centuries wrote about pigmented tumors that returned after removal. These early observations captured what we now call melanoma—skin cancer that tends to grow and spread if not caught early—long before doctors understood why it happened.
First described in the medical literature as a distinct, melanotic tumor in the early 1800s, melanoma was initially recognized by its look and behavior rather than by its biology. Early treatments focused on wide surgical removal, because doctors saw that leaving any part behind increased the chance of the cancer coming back. From these first observations, the idea of catching melanoma early became central to care.
As medical science evolved, better microscopes showed that melanoma starts in pigment‑making cells in the skin. By the mid‑20th century, pathologists mapped out how deep the tumor had grown and how that depth linked to the risk of spread. This led to the practice of checking nearby lymph nodes and using standardized staging systems, which helped doctors compare outcomes and refine treatment.
In recent decades, knowledge has built on a long tradition of observation. Researchers connected rising rates of melanoma with more sun exposure and tanning, especially intermittent, intense ultraviolet (UV) light that causes sunburns. Public health campaigns introduced sunscreen, protective clothing, and skin checks. Many living with melanoma learned the ABCDEs—watching for moles that change in shape, color, or size—as a way to spot early symptoms of melanoma on their own skin.
Advances in genetics transformed the field. Scientists discovered that certain inherited changes raise risk in some families, and that many melanomas carry specific mutations that act like stuck “on” switches for cell growth. These insights opened the door to targeted medicines and immune therapies that began to change survival for advanced melanoma in the 2010s. Once considered rare, now recognized as one of the most serious skin cancers, melanoma is treated today with a blend of careful surgery, tailored drug therapy, and ongoing skin surveillance.
Over time, the way the condition has been understood has changed, but the core lesson has stayed steady: early detection and protection from UV light save lives. Looking back helps explain today’s approach—know your skin, seek prompt evaluation of changing spots, and use modern treatments when needed, informed by both decades of careful observation and today’s biologic insight.